Law firm Barry Nilsson has been hit with proceedings by a former client who says was not informed the initial costs estimate of $6,000 provided by the firm had ballooned to $50,000 until her costs exceeded $32,000.
The co-owners of Pacific Werribee shopping centre in Victoria have largely won their bid for insurance documents as they weigh a second case against collapsed construction company, allegedly worth up to $335 million.
A US-based animal genomics company has taken Australia’s leading livestock and dairy groups to court, alleging they have infringed its patent for a system for conducting genetic testing on beef and dairy cattle by doing genetic testing without a licence.
A judge has signed off on a bill that brings the total settlement administration costs in a class action against Johnson & Johnson unit De Puy to over $13 million, amid a push by some judges to open the settlement administration gig up to competition.
Companies and government entities paid out less to settle class actions in 2023 than in the previous two years, with no mega settlements hitting their pocketbooks.
The owner of a car parking patent has appealed a judgment that tossed its patent infringement claims and found it made unjustified litigation threats against car parking technology company Ubipark.
The Sex Discrimination Commissioner has told a court a transgender woman who was excluded from female social network Giggle for Girls can bring a claim for gender identity discrimination under under Gillard-era amendments to the Sex Discrimination Act.
A judge has approved a $41.45 million settlement in a pelvic mesh class action against manufacturers Covidien and TFS but has put off deciding on the costs of the firm that ran the case, saying it is “next to useless” when law firms appoint their own costs consultants.
After winning a rare injunction restraining the owners of a patent from threatening litigation, carparking technology company UbiPark has prevailed in its claim the threats — aimed at itself and its customers — were unjustified.
A class action over pelvic mesh products supplied by device makers Covidien and TFS has reached a global resolution with the manufacturers and their insurers which brings the recovery total in settled mesh class action close to $450 million.